Bionxt Solutions Inc (BNXTF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 226 | 61 | 269 | 447 | 259 |
| Receivables | 84 | 70 | 209 | 242 | 273 |
| TOTAL | $460 | $195 | $533 | $755 | $586 |
| Non-Current Assets | |||||
| PPE Net | 327 | 390 | 406 | 652 | 683 |
| Other Non-Current Assets | 0 | 0 | 0 | 7 | 12 |
| TOTAL | $327 | $390 | $406 | $658 | $695 |
| Total Assets | $787 | $585 | $939 | $1,414 | $1,281 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,919 | N/A | 3,626 | 1,943 | 1,754 |
| Accounts payable and accrued liabilities | 1,314 | 1,223 | 1,113 | 774 | 828 |
| Other current liabilities | 35 | 112 | 114 | N/A | N/A |
| TOTAL | $5,268 | $1,335 | $4,852 | $2,723 | $2,595 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 3,794 | 0 | 1,710 | 1,693 |
| TOTAL | $N/A | $3,794 | $N/A | $1,710 | $1,693 |
| Total Liabilities | $5,268 | $5,129 | $4,852 | $4,433 | $4,288 |
| Shareholders' Equity | |||||
| Common Shares | 38,255 | 38,107 | 37,595 | 37,197 | 36,125 |
| Retained earnings | -45,652 | -45,592 | -44,395 | -44,378 | -43,244 |
| Other shareholders' equity | 2,916 | 2,941 | 2,886 | 4,161 | 4,113 |
| TOTAL | $-4,481 | $-4,544 | $-3,913 | $-3,020 | $-3,007 |
| Total Liabilities And Equity | $787 | $585 | $939 | $1,414 | $1,281 |